These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5614275)
21. "BOUND" COMPLEMENT IN THE SKIN OF PATIENTS WITH CHRONIC DISCOID LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS. KALSBEEK GL; CORMANE RH Lancet; 1964 Jul; 2(7352):178-80. PubMed ID: 14163132 [No Abstract] [Full Text] [Related]
22. The relationship between discoid lupus erythematosus and systemic lupus erythematosus. A hypothesis. Provost T Am J Dermatopathol; 1979; 1(2):181-4. PubMed ID: 549495 [No Abstract] [Full Text] [Related]
23. [Relationship between serum complement titer (CH50), immune adherence (IA), beta-1-A-globulin, transferrin, IgA, IgM and IgG in SLE]. Ishikawa Y Arerugi; 1969 Dec; 18(12):966-72. PubMed ID: 4189140 [No Abstract] [Full Text] [Related]
29. Silent lupus nephritis among patients with discoid lupus erythematosus. Roujeau JC; Belghiti D; Hirbec G; Poli F; Sobel AT; Revuz J; Touraine R Acta Derm Venereol; 1984; 64(2):160-3. PubMed ID: 6203307 [TBL] [Abstract][Full Text] [Related]
30. Lupus erythematosus. Cramer SF Am J Dermatopathol; 1981; 3(2):233-4. PubMed ID: 7270819 [No Abstract] [Full Text] [Related]
31. Antibodies to native DNA in discoid lupus erythematosus. Davis P; Atkins B; Hughes GR Br J Dermatol; 1974 Aug; 91(2):175-81. PubMed ID: 4412050 [No Abstract] [Full Text] [Related]
32. [Chronic discoid lupus erythematosus as a disease in internal medicine, with special reference to the cases with difficulty in differentiation from SLE]. Okuda M; Nishido T; Okamoto S Naika; 1971 Apr; 27(4):752-60. PubMed ID: 4101751 [No Abstract] [Full Text] [Related]
33. [Immunologic and immunogenetic heterogeneity of systemic and discoid lupus erythematosus]. Konenkov VI; Korotkova IIu; Prokof'ev VF; Petrova EM; Lozovoĭ VP Ter Arkh; 1989; 61(5):31-4. PubMed ID: 2781486 [TBL] [Abstract][Full Text] [Related]
34. Deposits of immunoglobulins and complement C3 in clinically normal skin of patients with lupus erythematosus. Ullman S; Halberg P; Wolf-Jürgensen P Acta Derm Venereol; 1975; 55(2):109-12. PubMed ID: 48312 [TBL] [Abstract][Full Text] [Related]
36. Autoantibody and clinical profiles in patients with discoid lupus and borderline systemic lupus. Vasquez R; Tseng LC; Victor S; Zhang S; Chong BF Arch Dermatol; 2012 May; 148(5):651-5. PubMed ID: 22782164 [No Abstract] [Full Text] [Related]
37. Direct cutaneous immunofluorescent test in lupus erythematosus. Nesbitt LT; Gum OB South Med J; 1973 Sep; 66(9):991-7. PubMed ID: 4126199 [No Abstract] [Full Text] [Related]
38. Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of lupus erythematosus. Błaszczyk M; Majewski S; Wasik M; Chorzelski T; Jabłonska S Br J Dermatol; 1987 Dec; 117(6):709-14. PubMed ID: 3426951 [TBL] [Abstract][Full Text] [Related]
39. Autoantibodies in patients with Lupus erythematosus: spectrum and frequencies. Wenzel J; Bauer R; Bieber T; Böhm I Dermatology; 2000; 201(3):282-3. PubMed ID: 11096213 [No Abstract] [Full Text] [Related]
40. [Observations on the antistreptolysin-A level in patients with lupus erythematosus and psoriasis]. Markevich VS Vestn Dermatol Venerol; 1968 Mar; 42(3):51-5. PubMed ID: 5741245 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]